Interestingly, a genetic variant in the promoter region regulating the expression of uncoupling protein 2 (UCP2) has recently been associated with altered lipoprotein metabolism and reduced susceptibility to NASH [117]. This evidence concerns the gene UCP2 and metabolic dysfunction-associated steatohepatitis.